Dr. Marc J. Kahn

Request as Speaker

Request as Media Expert

Chief of Hematology, Department of Internal Medicine

Expertise: Medicine, Hematology, Oncology, Health education, Business of medicine

Biography

Dr. Marc J. Kahn is chief of hematology at the Kirk Kerkorian School of Medicine's Department of Internal Medicine. He is a prolific researcher in benign hematology, medical education, and healthcare finance.

He has served in leadership roles with the Association of American Medical Colleges, American College of Physicians, American Society of Hematology, National Board of Medical Examiners, and the National Residency Matching Program.

Dr. Kahn has authored over 100 peer-reviewed manuscripts in addition to 110 book chapters and five textbooks. In 2020, his most recent textbook, “Business Basics of Building and Managing a Healthcare Practice,” was published by Springer Nature.

He formerly served as vice president for health affairs at UNLV and as dean of the university's medical school — developing curricula, clinical programs, and research to elevate healthcare in the region. Prior to joining UNLV in April 2020, Dr. Kahn was a senior associate dean at Tulane University School of Medicine.

Education

M.D., University of Pennsylvania School of Medicine
M.B.A., Tulane University
B.A., Chemistry, University of Pennsylvania

Search For Other Experts On

health & medicine

Dr. Marc J. Kahn In The News

UNLV doctor explains how pneumonia can turn to sepsis after Kyle Busch death

Sepsis is a life-threatening condition that can occur when the body has an extreme response to an infection. In this case, the infection was pneumonia, which can start in the lungs and, in severe cases, lead to sepsis.

How to Manage Period Pain in Sickle Cell Disease

Everyday Health

Having your period when you also have sickle cell disease (SCD) can pose unique challenges, including more severe cramps. Blood loss and fluctuating hormones can even set off a sickle cell crisis.

What's the future of AI in medicine research and discovery?

The Wall Street Journal first reported that Biopharmaceutical giant Bristol Myers Squibb is bringing Anthropic’s flagship Claude product to more than 30,000 of its employees. The company plans to deepen its use of artificial intelligence and AI agents for a variety of functions, from research to clinical development and corporate functions.

EDC returns this weekend, experts share safety reminders ahead of the festival

While the official festival kicks off Friday, a parade is set to run through the Las Vegas Strip tomorrow to usher in the event. With the large crowds expected, experts are emphasizing the importance of planning for security concerns, heat safety and potential medical emergencies.